103 related articles for article (PubMed ID: 3054743)
41. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
[TBL] [Abstract][Full Text] [Related]
42. [Antibacterial effect of cefixime].
Soussy CJ; Meyran M; Duval J
Presse Med; 1989 Oct; 18(32):1546-50. PubMed ID: 2530528
[TBL] [Abstract][Full Text] [Related]
43. [Antibacterial activity of enoxacin in vitro and in urine].
Soussy CJ; Deforges L; Duval J
Pathol Biol (Paris); 1987 May; 35(5):475-81. PubMed ID: 3302849
[TBL] [Abstract][Full Text] [Related]
44. [In vitro effect of piperacillin on aerobic bacteria. Variations according to the phenotypes of resistance to beta-lactam antibiotics].
Jarlier V; Soussy CJ; Chanal M; Sirot D; Le Van Thoi J; Bismuth R; Grosset J; Duval J; Cluzel R
Presse Med; 1986 Dec; 15(46):2272-8. PubMed ID: 2949267
[TBL] [Abstract][Full Text] [Related]
45. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
Matsuo K; Uete T
Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
[TBL] [Abstract][Full Text] [Related]
46. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
Neu HC; Labthavikul P
Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
[TBL] [Abstract][Full Text] [Related]
47. [Multicenter study of the activity of pefloxacin on bacteria isolated in a hospital milieu].
Soussy CJ; Acar JF; Bergogne-Berezin E; Christol D; Courtieu AL; Duval J; Fleurette J; Lareng MB; Morel C; Thabaut A
Rev Med Interne; 1986 Mar; 7(2):197-204. PubMed ID: 3459222
[TBL] [Abstract][Full Text] [Related]
48. [Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].
Uete T; Matsuo K
Jpn J Antibiot; 1987 Nov; 40(11):1906-16. PubMed ID: 3327966
[TBL] [Abstract][Full Text] [Related]
49. [Sensitivity of bacteria causing urinary tract infections towards terizidon (author's transl)].
Wewalka G; Rotter M; Fischer A
Wien Klin Wochenschr; 1976 May; 88(11):355-60. PubMed ID: 826024
[TBL] [Abstract][Full Text] [Related]
50. A microbiological evaluation of apalcillin.
Wiedemann B; Seeberg A
Infection; 1983; 11(6):340-4. PubMed ID: 6421745
[TBL] [Abstract][Full Text] [Related]
51. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476
[TBL] [Abstract][Full Text] [Related]
52. The in-vitro activity of cefodizime: a review.
Soussy CJ; Chanal M; Kitzis MD
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
[TBL] [Abstract][Full Text] [Related]
54. [In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Chanal M; Cluzel M; Fleurette J; Forey F; Thabaut A; Meyran M; Vandekerkove M; Sicard D; Acar JF; Kitzis MD; Veron M; Fauchere JL
Pathol Biol (Paris); 1983 Jun; 31(6):504-8. PubMed ID: 6348657
[TBL] [Abstract][Full Text] [Related]
55. Correlation between beta-lactamase production and MIC values against penicillin with coagulase negative staphylococci.
Narayani TV; Shanmugam J; Naseema K; Bhattacharya RN; Shyamkrishnan KG
J Postgrad Med; 1989 Jul; 35(3):147-51. PubMed ID: 2634755
[TBL] [Abstract][Full Text] [Related]
56. [Clinical laboratory approach in estimating the effective dosage of cefamandole].
Uete G; Matsuo K; Uete T
Jpn J Antibiot; 1988 Jun; 41(6):631-40. PubMed ID: 3221428
[TBL] [Abstract][Full Text] [Related]
57. Population analysis of susceptibility to ciprofloxacin and nalidixic acid in Staphylococcus, Pseudomonas aeruginosa, and Enterobacteriaceae.
Søgaard P; Gahrn-Hansen B
Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):351-6. PubMed ID: 3098043
[TBL] [Abstract][Full Text] [Related]
58. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
[TBL] [Abstract][Full Text] [Related]
59. Correlation of minimum inhibitory concentration and beta-lactamase activity.
Ullmann U
Infection; 1977; 5(4):261-2. PubMed ID: 340386
[TBL] [Abstract][Full Text] [Related]
60. [Experimental criteria for interpretation of bacterial sensitivity to dioxidine determined by diffusion from the disks].
Ponomareva TR; Malakhova VA
Antibiot Khimioter; 1990 Jul; 35(7):23-5. PubMed ID: 2126705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
